FANews
FANews
RELATED CATEGORIES
Category Healthcare
SUB CATEGORIES General  |  HIV |  Medical Schemes | 

Ambledown expands range of outpatient treatments covered

20 October 2022 Ambledown Financial Services

At its annual virtual product launch, Ambledown Financial Services has revealed a comprehensive range of extensions to its gap cover for the coming year.

“Ambledown’s gap cover is designed to help South Africans continue accessing the best medical care without compromising their financial security by covering the difference between what medical schemes pay and what consultants and hospitals actually charge,” says Michael Emery, Marketing Executive at Ambledown. “Every year we try to push the limits of what we cover a little further in order to serve our members better. This year is no exception.”

A major theme of the launch was an extension of the range of cancer treatments covered. African cancer mortality rates are set to double by 2030, with more than a million lives likely to be lost per year. [i]

“Ambledown has extended its oncology benefits fairly aggressively this year in response to this looming crisis – we want our members and their families to have the best chance of recovery. Our cover now includes nuclear scans limited to the mapping for cancer and numerous ground-breaking immunotherapies, hormone therapy, targeted therapy, photodynamic therapy and stem cell transplants,” Emery says. “We are very conscious of the need for our cover to keep up with new treatments as their efficacy is confirmed.”

At the launch, Ambledown also announced that the range of procedures covered on an outpatient basis will be increased. Additional haemorrhoidectomy treatments, excision of particular skin lesions, vacuum biopsy of the breast and circumcisions have all been added to its list of outpatient procedures.

Medical inflation is a key challenge, and a survey commissioned by Ambledown shows that the increases planned by medical schemes are significantly below the increases contemplated by medical specialists, something that will have a major impact on gap cover claims.

In line with this massive increase in specialists’ fees, Ambledown will also increase its current annual overall limit of R185 837 in April 2023 in line with the regulator’s directive.

“Ambledown prides itself on keeping up with this runaway medical inflation while still expanding its cover and continuing to offer its members stable premiums,” Emery concludes. “We will maintain our focus on innovation aimed at providing our members with gap cover that truly makes a difference.”

Ambledown Financial Services is authorised Financial Services Provider No.10287

[i] https://www.news24.com/health24/medical/cancer/one-million-people-could-die-of-cancer-annually-in-sub-saharan-africa-by-2030-20220510#:~:text=Cancer%20researchers%20estimate%20that%20annual,deaths%20that%20occurred%20in%202020.

Quick Polls

QUESTION

South Africa’s economy is facing major policy and market challenges in 2025. As an adviser or broker, what concerns you the most?

ANSWER

Erosion of private property rights
Government interference in free trade
Inflation, administered prices
Weak growth, high debt
fanews magazine
FAnews February 2025 Get the latest issue of FAnews

This month's headlines

Unseen risks: insuring against the impact of AI gone wrong
Machine vs human: finding the balance
Is embedded insurance the end of traditional broker channels?
Client aspirations take centre stage as advisers rethink retirement planning
Maximise TFSA contributions before year-end
Subscribe now